Record Information
Version1.0
Creation Date2016-05-22 04:23:28 UTC
Update Date2016-11-09 01:15:36 UTC
Accession NumberCHEM017481
Identification
Common NameCaptopril
ClassSmall Molecule
DescriptionCaptopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE), the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Captopril may be used in the treatment of hypertension.
Contaminant Sources
  • HMDB Contaminants - Urine
  • STOFF IDENT Compounds
  • ToxCast & Tox21 Chemicals
Contaminant TypeNot Available
Chemical Structure
Thumb
Synonyms
ValueSource
(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acidChEBI
AcepressChEBI
ApoprilChEBI
CapotenChEBI
CaptolaneChEBI
CaptoprilumChEBI
CaptoprylChEBI
CaptorilChEBI
CesplonChEBI
CPChEBI
D-2-Methyl-3-mercaptopropanoyl-L-prolineChEBI
D-3-Mercapto-2-methylpropanoyl-L-prolineChEBI
DilabarChEBI
GarranilChEBI
HypertilChEBI
L-CaptoprilChEBI
LopirinChEBI
TenosbonChEBI
TensobonChEBI
TensoprelChEBI
(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylateGenerator
(2S)-1-[(2S)-2-Methyl-3-sulphanylpropanoyl]pyrrolidine-2-carboxylateGenerator
(2S)-1-[(2S)-2-Methyl-3-sulphanylpropanoyl]pyrrolidine-2-carboxylic acidGenerator
(S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-prolineHMDB
Chemical FormulaC9H15NO3S
Average Molecular Mass217.285 g/mol
Monoisotopic Mass217.077 g/mol
CAS Registry Number62571-86-2
IUPAC Name(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
Traditional Namecaptopril
SMILESC[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
InChI IdentifierInChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1
InChI KeyFAKRSMQSSFJEIM-RQJHMYQMSA-N
Chemical Taxonomy
Description belongs to the class of organic compounds known as proline and derivatives. Proline and derivatives are compounds containing proline or a derivative thereof resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentProline and derivatives
Alternative Parents
Substituents
  • N-acyl-alpha-amino acid
  • N-acyl-alpha amino acid or derivatives
  • N-acyl-l-alpha-amino acid
  • Proline or derivatives
  • N-acylpyrrolidine
  • Pyrrolidine carboxylic acid
  • Pyrrolidine carboxylic acid or derivatives
  • Pyrrolidine
  • Tertiary carboxylic acid amide
  • Carboxamide group
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Alkylthiol
  • Azacycle
  • Organoheterocyclic compound
  • Organonitrogen compound
  • Hydrocarbon derivative
  • Organopnictogen compound
  • Organic oxygen compound
  • Organooxygen compound
  • Organosulfur compound
  • Carbonyl group
  • Organic oxide
  • Organic nitrogen compound
  • Aliphatic heteromonocyclic compound
Molecular FrameworkAliphatic heteromonocyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
PathwaysNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility4.52 g/LALOGPS
logP1.02ALOGPS
logP0.73ChemAxon
logS-1.7ALOGPS
pKa (Strongest Acidic)4.02ChemAxon
pKa (Strongest Basic)-1.2ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area57.61 ŲChemAxon
Rotatable Bond Count3ChemAxon
Refractivity54.63 m³·mol⁻¹ChemAxon
Polarizability21.72 ųChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyView
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positivesplash10-002f-9400000000-51d6dae57d8b305064acSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (1 TMS) - 70eV, Positivesplash10-00fr-9410000000-65f35f9df00d94abb290Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-qTof , Positivesplash10-014i-0940000000-26ddf220b67fb8dcdff0Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , negativesplash10-001i-0910000000-8797427ebbfead8313f9Spectrum
LC-MS/MSLC-MS/MS Spectrum - , positivesplash10-014i-0940000000-26ddf220b67fb8dcdff0Spectrum
LC-MS/MSLC-MS/MS Spectrum - , positivesplash10-01b9-8910000000-d831e8d48402a4c5fe73Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-01b9-9720000000-8218e12ef8f7e988c312Spectrum
LC-MS/MSLC-MS/MS Spectrum - 10V, Positivesplash10-014i-0490000000-368990ca74ad93e14251Spectrum
LC-MS/MSLC-MS/MS Spectrum - 10V, Positivesplash10-014i-0290000000-1fecd0b4a33bc6afc4f2Spectrum
LC-MS/MSLC-MS/MS Spectrum - 20V, Positivesplash10-01b9-0940000000-089a033b51be30f3a297Spectrum
LC-MS/MSLC-MS/MS Spectrum - 10V, Positivesplash10-014i-3950000000-02525f49c5ae7c64e751Spectrum
LC-MS/MSLC-MS/MS Spectrum - 50V, Positivesplash10-00di-9100000000-2d3dff49389d32966270Spectrum
LC-MS/MSLC-MS/MS Spectrum - 50V, Positivesplash10-00di-9000000000-5fec50f211615a61cd58Spectrum
LC-MS/MSLC-MS/MS Spectrum - 30V, Positivesplash10-00di-9200000000-955e87fa6bbc3b688dc5Spectrum
LC-MS/MSLC-MS/MS Spectrum - 30V, Positivesplash10-00di-9300000000-12f0a42fb63fd9a341e4Spectrum
LC-MS/MSLC-MS/MS Spectrum - 30V, Positivesplash10-00di-9100000000-8a3f39d9e1f9e0ddfa3aSpectrum
LC-MS/MSLC-MS/MS Spectrum - 35V, Positivesplash10-01b9-9720000000-cc5d5a56e386ed3da5dfSpectrum
LC-MS/MSLC-MS/MS Spectrum - 35V, Negativesplash10-001i-0910000000-8797427ebbfead8313f9Spectrum
LC-MS/MSLC-MS/MS Spectrum - 50V, Positivesplash10-014i-4920000000-abe7ab7a43bb4ab37f27Spectrum
LC-MS/MSLC-MS/MS Spectrum - 10V, Positivesplash10-014i-0390000000-443943c884569fe9bddeSpectrum
LC-MS/MSLC-MS/MS Spectrum - 10V, Positivesplash10-014i-2950000000-6310d54f5354a953ff47Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-014i-0890000000-6471cadb8251b2cde228Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-0uk9-3920000000-93e7eef38f7bf8d57f56Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-0udi-9400000000-f8b12a12ec76d0508922Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-00lr-1930000000-21d83329a778cc965f80Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-00yr-2910000000-30e872740f7cb996700dSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-015c-9500000000-9c8558c81f9491de8c08Spectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
Toxicity Profile
Route of ExposureNot Available
Mechanism of ToxicityNot Available
MetabolismNot Available
Toxicity ValuesNot Available
Lethal DoseNot Available
Carcinogenicity (IARC Classification)Not Available
Uses/SourcesNot Available
Minimum Risk LevelNot Available
Health EffectsNot Available
SymptomsNot Available
TreatmentNot Available
Concentrations
Not Available
DrugBank IDDB01197
HMDB IDHMDB0015328
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDX8Z
Wikipedia LinkCaptopril
Chemspider ID40130
ChEBI ID3380
PubChem Compound ID44093
Kegg Compound IDNot Available
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. Atkinson AB, Robertson JI: Captopril in the treatment of clinical hypertension and cardiac failure. Lancet. 1979 Oct 20;2(8147):836-9.
2. Patchett AA, Harris E, Tristram EW, Wyvratt MJ, Wu MT, Taub D, Peterson ER, Ikeler TJ, ten Broeke J, Payne LG, Ondeyka DL, Thorsett ED, Greenlee WJ, Lohr NS, Hoffsommer RD, Joshua H, Ruyle WV, Rothrock JW, Aster SD, Maycock AL, Robinson FM, Hirschmann R, Sweet CS, Ulm EH, Gross DM, Vassil TC, Stone CA: A new class of angiotensin-converting enzyme inhibitors. Nature. 1980 Nov 20;288(5788):280-3.
3. Smith CG, Vane JR: The discovery of captopril. FASEB J. 2003 May;17(8):788-9.
4. https://www.ncbi.nlm.nih.gov/pubmed/?term=23137627
5. https://www.ncbi.nlm.nih.gov/pubmed/?term=23161035
6. https://www.ncbi.nlm.nih.gov/pubmed/?term=23278692
7. https://www.ncbi.nlm.nih.gov/pubmed/?term=23299024
8. https://www.ncbi.nlm.nih.gov/pubmed/?term=23328620
9. https://www.ncbi.nlm.nih.gov/pubmed/?term=23397376
10. https://www.ncbi.nlm.nih.gov/pubmed/?term=23410042
11. https://www.ncbi.nlm.nih.gov/pubmed/?term=23422724
12. https://www.ncbi.nlm.nih.gov/pubmed/?term=23429803
13. https://www.ncbi.nlm.nih.gov/pubmed/?term=23435971
14. https://www.ncbi.nlm.nih.gov/pubmed/?term=2420897